P. Enns
Director/Board Member at WAVERLEY PHARMA INC.
Net worth: 2 100 $ as of 29/04/2024
Profile
Marcus Enns is a Managing Director in Brookfield’s Renewable Power & Transition Group.
In this role, he is responsible for the strategy and execution of project and acquisition financing globally.
Mr. Enns has held several roles for the group, including overseeing North American capital markets, treasury and financial planning functions.
Prior to joining Brookfield in 2007, Mr. Enns worked for a large Canadian power utility.
Mr. Enns holds a Bachelor of Commerce degree from the Asper School of Business at the University of Manitoba and is a CFA® charterholder.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
WAVERLEY PHARMA, INC.
0.19% | 07/05/2023 | 100,000 ( 0.19% ) | 2 100 $ | 29/04/2024 |
P. Enns active positions
Companies | Position | Start |
---|---|---|
WAVERLEY PHARMA INC. | Director/Board Member | 13/12/2016 |
Genesys Venture, Inc.
Genesys Venture, Inc. Financial ConglomeratesFinance Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada. | Corporate Officer/Principal | 31/12/1999 |
Rosenort Credit Union Ltd. | Chairman | - |
Marsala Biotech Inc
Marsala Biotech Inc BiotechnologyHealth Technology Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada. | Director/Board Member | - |
CanAm Bioresearch, Inc.
CanAm Bioresearch, Inc. BiotechnologyHealth Technology CanAm Bioresearch, Inc. operates as pharmaceutical contract research organization. It offers synthetic organic chemistry and medicinal chemistry research services; analytical chemistry and bioanalysis services, such as HPLC-UV, LC-MS, plasma level, blood level, tissue distribution analysis. The company was founded in 2000 and is headquartered in Winnipeg, Canada. | President | - |
Brookfield Timberlands Management LP
Brookfield Timberlands Management LP Investment ManagersFinance Brookfield Timberlands Management LP is a private equity firm headquartered in Toronto, Ontario. The firm is a division of Brookfield Specialty Funds/Private Capital and their ultimate parent is Brookfield Asset Management, Inc. (NYSE: BAM). | Private Equity Investor | 31/12/2006 |
Former positions of P. Enns
Companies | Position | End |
---|---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Public Communications Contact | 03/05/2012 |
KANE BIOTECH INC. | Public Communications Contact | 30/11/2010 |
BIG SKY PETROLEUM CORPORATION | Director/Board Member | 30/04/2008 |
░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of P. Enns
University of Manitoba | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
KANE BIOTECH INC. | Commercial Services |
WAVERLEY PHARMA INC. | Health Technology |
Private companies | 8 |
---|---|
Luminor Medical Technologies, Inc.
Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Luminor Medical Technologies, Inc. engages in acquiring, developing and commercializing non-invasive technologies for unmet clinical needs. It develops technology programs: Scout DS Diabetes Screen, PreVu Skin Cholesterol Test for fiabetes, and coronary artery disease. The company was founded on June 27, 1998 and is headquartered in Toronto, Canada. | Commercial Services |
Brookfield Timberlands Management LP
Brookfield Timberlands Management LP Investment ManagersFinance Brookfield Timberlands Management LP is a private equity firm headquartered in Toronto, Ontario. The firm is a division of Brookfield Specialty Funds/Private Capital and their ultimate parent is Brookfield Asset Management, Inc. (NYSE: BAM). | Finance |
Genesys Venture, Inc.
Genesys Venture, Inc. Financial ConglomeratesFinance Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada. | Finance |
Big Sky Petroleum Corp.
Big Sky Petroleum Corp. Oil & Gas ProductionEnergy Minerals Big Sky Petroleum Corp. is an oil and gas exploration and production company with operations in Montana and Texas. It is focused on the development of unconventional tight oil reservoirs in the Southern Alberta Basin of Montana and the Southern Midland Basin in West Texas. The company was founded on February 3, 2006 and is headquartered in Vancouver, Canada. | Energy Minerals |
Buffalo Capital, Inc.
Buffalo Capital, Inc. Financial ConglomeratesFinance Buffalo Capital, Inc. engages in the identification and evaluation of interest in properties, assets or businesses. The company was founded on December 14, 2016 and is headquartered in Winnipeg, Canada. | Finance |
Rosenort Credit Union Ltd. | |
Marsala Biotech Inc
Marsala Biotech Inc BiotechnologyHealth Technology Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada. | Health Technology |
CanAm Bioresearch, Inc.
CanAm Bioresearch, Inc. BiotechnologyHealth Technology CanAm Bioresearch, Inc. operates as pharmaceutical contract research organization. It offers synthetic organic chemistry and medicinal chemistry research services; analytical chemistry and bioanalysis services, such as HPLC-UV, LC-MS, plasma level, blood level, tissue distribution analysis. The company was founded in 2000 and is headquartered in Winnipeg, Canada. | Health Technology |
- Stock Market
- Insiders
- P. Enns